SOURCE: Skinvisible, Inc

February 11, 2010 09:05 ET

Skinvisible's Safe4Hours Promotion in Walgreens Expands

Licensee Receives Third Order in 2010

LAS VEGAS, NV--(Marketwire - February 11, 2010) - Skinvisible, Inc. (OTCBB: SKVI) announces JD Nelson and Associates LLC, its license holder of the newly launched Safe4Hours® First Aid Antiseptic Skin Protectant, is expanding their presence in Walgreens stores with a special marketing promotion. This includes a third nationwide order that JD Nelson has received since the initial launch three weeks ago. The promotion includes prominent end-cap point of purchase displays which will profile Safe4Hours in 4,100 Walgreens. This heightened visibility along with a television advertising campaign, will educate consumers about the product's benefits. This first aid antiseptic lotion, formulated with the patented Invisicare® delivery system, binds to the skin, resisting both wash off and perspiration while continuing to kill harmful bacteria for up to four hours.

"We are excited about our successful launch of Safe4Hours and the reorders that ensued from Walgreens," said Doug Nelson, President, JD Nelson and Associates. "We are working hand in hand with Walgreens on this new campaign which provides additional national exposure of our new product made with Invisicare. Safe4Hours First Aid Antiseptic Skin Protectant will be prominently displayed, grabbing the attention of the consumer and ultimately a sale. We have also incorporated a TV marketing campaign into this promotion, profiling the dual benefits of Safe4Hours in major US markets. Along with being a first aid antiseptic that protects you from infection, Safe4Hours is also a skin protectant that protects your hands, face and body from the drying effects of weather year round."

Safe4Hours First Aid Antiseptic Skin Protectant is an important product to stop the spread of skin infections. Athletes in particular, including professionals, amateurs and even school children are all highly susceptible to contracting a skin infection due to the high level of contact in most sports. The Center for Disease Control states that "prevention is better than cure" and Safe4Hours® First Aid Antiseptic Skin Protectant provides that protection. It reduces the spread of a broad spectrum of bacteria including MRSA (methicillin-resistant Staphylococcus aureus) which can be found not only in gyms and locker rooms across the country but throughout the community.

About Skinvisible Pharmaceuticals, Inc

Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing irritation. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible's value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com

Forward-Looking Statements: This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10K for the quarter ending October 31, 2009).

Contact Information

  • Corporate Contact:
    Doreen McMorran
    Skinvisible Pharmaceuticals, Inc.
    Phone: 702-433-7154
    Email: Email Contact